MIMAC™ GyroScopic
Coronary Bypass Platform
Clinical Objective
Develop a fully non-invasive, magnetically aligned coronary bypass system that enables deterministic placement of a Y-junction bypass at a target coronary artery using inertial-stabilized continuum surgery. The platform minimizes tissue trauma and supports long-term patency while enabling future inspection and intervention.
The system integrates:
-
Y-junction bypass implant (MIMAC-Y Nexus™)
-
A stent-delivered magnetic docking anchor (MIMAC Dock-2™)
-
An inertial surgical intelligence head (GyroPoint™)
-
A sacrificial peristaltic access conduit (BioSheath™ PeriPath™)
-
Biomimetic locomotion physics (AnisoGrip™)
-
Bio-assimilating material systems (BioAssim™)
Platform Architecture Overview
The GyroPoint™ head is the surgical instrument.
All other components exist to deliver, stabilize, align, and biologically integrate that instrument with minimal trauma.
The access pathway is intentionally slow, soft, and sacrificial to reduce tissue injury. Surgical time may increase, but vascular and myocardial trauma is reduced relative to rigid, force-driven approaches.
Implant Subsystem: MIMAC-Y Nexus™
Functional Role
A magnetically docked Y-junction bypass interface that terminates precisely at the coronary artery, restoring flow.
Structural Design
-
Y-geometry optimized for laminar flow continuity and minimized shear gradients
-
Both legs terminate cleanly at the artery interface; no extension beyond the anastomotic region
-
Compliance-matched body to reduce neointimal hyperplasia driven by stiffness mismatch
Biomaterials (Implant Body)
-
Primary substrate: elastomeric polycarbonate-urethane (PCU class) with fatigue resistance under cyclic cardiac loading
-
Embedded micro-reinforcement (optional): compliant knit or braid for kink resistance without rigidification
Luminal Surface (Blood-Contacting)
-
Zwitterionic antifouling layer to reduce protein adsorption
-
Covalently bound heparin or nitric-oxide-generating chemistry to suppress platelet activation
-
Smooth microtopography to avoid recirculation pockets and flow separation
Exterior Surface (Tissue-Facing)
-
Zoned porosity to encourage stable fibrous integration without constrictive scarring near the coronary interface
-
Mechanical anchoring on the subcutaneous access leg
Docking & Anchoring Subsystem: MIMAC Dock-2™
Delivery Pathway
-
Deployed via leg-artery access using a specialized stent-based delivery method
Docking Architecture
-
Two spatially separated magnetic capture points create a rotationally keyed docking constraint
-
Magnetic alignment is supplemented by passive mechanical geometry to eliminate magnet-only dependency
Materials
-
Magnet cores fully encapsulated in corrosion-proof, bioinert barriers (e.g., titanium or multilayer ceramic/polymer encapsulation)
-
Radiopaque markers provide imaging verification of orientation and engagement
Docking Verification
-
Visual alignment markers
-
Known force-signature upon magnetic capture
-
Optional passive resonant or electrical verification features
Surgical Instrumentation: GyroPoint™
Functional Definition
An inertial-stabilized surgical intelligence head that performs:
-
Tissue Piercing
-
Infinite Degrees of Freedom Navigation
-
Alignment
-
Interface conditioning
-
Placement verification
-
Optics
GyroScopic Control Layer
-
Continuous inertial reference frame decoupled from body curvature
-
Real-time compensation for cardiac and respiratory motion
-
Stable tip pose is maintained even while the access pathway remains curved
End-Effector Capabilities
-
Atraumatic micro-conditioning of the coronary interface
-
Localized tissue preparation without intimal damage
-
Controlled sealing and stabilization of the Nexus interface
Access & Locomotion System: BioSheath™ PeriPath™
Conceptual Role
A sacrificial, peristaltic, bio-assimilating access conduit that forms a temporary surgical corridor.
Mechanical Behavior
-
Soft, translucent tubular body
-
Segmental peristaltic motion rather than push-force insertion
-
Anti-backslide locomotion via AnisoGrip™ micro-geometry
AnisoGrip™ Physics
-
Directional micro-ribs inspired by biological scale structures
-
Forward traction with passive collapse under reverse load
-
Minimizes tissue tearing and compressive injury
BioAssim™ Material Strategy
-
Selective bio-resorbable or physiologically cleared polymers
-
Option for partial retention in situ, where beneficial
-
Designed for non-inflammatory assimilation rather than extraction
Interface Conditioning & Sealing Process
After magnetic docking:
-
GyroPoint stabilizes the interface in an inertial reference frame
-
Controlled micro-conditioning prepares the adventitial surface
-
Sealing is performed using:
-
Mechanical stabilization
-
Bio-adhesive or polymer integration (optional)
-
Localized anti-proliferative conditioning if indicated
-
This avoids traditional suturing and reduces endothelial trauma. More research is slated to fully reveal this critical interface and method.
Subcutaneous Access & Long-Term Interrogation
Access Leg Design
-
The primary leg of the MIMAC-Y Nexus is sutured just below the skin surface
-
Stabilized for repeat needle access
Functional Purpose
-
Periodic inspection
-
Flow verification
-
Targeted intervention
Engineering Features
-
Self-sealing septum architecture
-
Infection-resistant outer surface
-
Needle-tolerant material stack
Advanced Inspection Integration
-
Micro-endoscopic and fiber-optic tools compatible with future iNanoScope-class imaging and analysis
-
Supports spectral, flow, and AI-assisted evaluation rather than open re-intervention
Healing Strategy: Exterior vs Interior Biology
Exterior (Desired Outcome)
-
Controlled fibrous encapsulation for mechanical stability
-
No migration or micromotion
Interior (Critical Constraint)
-
No neointimal hyperplasia
-
No chronic inflammation
-
No thrombus formation
Achieved through:
-
Compliance matching
-
Laminar flow geometry
-
Hemocompatible surface chemistry
-
Optional localized drug-elution at the junction
Validation & Development Milestones
M1: Materials Down-Selection
-
Finalize PCU substrate, luminal coating stack, BioAssim compositions
M2: Docking Fidelity
-
Demonstrate repeatable Dock-2 magnetic capture with orientation control
M3: Interface Conditioning Safety
-
Prove atraumatic preparation without endothelial damage
M4: Access Leg Longevity
-
Validate puncture endurance, sealing, and infection resistance
M5: Preclinical Feasibility
-
Patency, healing response, encapsulation behavior, and system stability
Strategic Positioning
This platform reframes coronary bypass as:
-
A soft, inertial, biologically cooperative process
-
Not a force-driven mechanical intervention
-
Designed for future inspection, not one-time permanence
It is inherently extensible to:
-
Multi-branch bypass
-
Peripheral vascular repair
-
Neurovascular and organ-specific flow restoration
GyroScopic™ Inertial Continuum Surgery for Magnetically Docked Coronary Bypass Using the MIMAC-Y Nexus™ Platform
Abstract
We present a non-invasive coronary bypass platform integrating magnetically docked vascular implants with inertial-stabilized continuum surgical instrumentation.
The system combines a biocompatible Y-junction bypass (MIMAC-Y Nexus™), a stent-delivered magnetic docking anchor (MIMAC Dock-2™), and an inertial surgical intelligence head (GyroPoint™) advanced through a sacrificial peristaltic access conduit (BioSheath™ PeriPath™).
The approach strives to eliminate open anastomosis, reduce endothelial trauma, and enable long-term post-implant interrogation via a subcutaneous access leg. The platform leverages biomimetic locomotion physics (AnisoGrip™) and bio-assimilating materials (BioAssim™) to minimize tissue disruption while maintaining deterministic placement and long-term patency.
Introduction
Traditional coronary bypass surgery relies on open exposure, sutured anastomosis, and rigid instrumentation that imposes significant mechanical and inflammatory stress on vascular tissue. Even minimally invasive and robotic approaches retain force-driven paradigms that elevate trauma risk and limit post-procedural access.
We propose a paradigm shift: inertial continuum surgery with magnetically aligned implants, in which biological cooperation replaces mechanical dominance.
System Overview
The platform consists of four integrated subsystems:
-
A magnetically docked Y-junction bypass implant
-
A femoral-delivered coronary docking anchor
-
An inertial-stabilized continuum surgical head
-
A sacrificial peristaltic access pathway
Each subsystem is independently validated yet interdependent in clinical execution.
Implant Design: MIMAC-Y Nexus
The bypass implant is fabricated from compliance-matched elastomeric polycarbonate-urethane with optional micro-reinforcement. Luminal surfaces employ antifouling and antithrombotic chemistry, while exterior surfaces promote controlled fibrous integration. The geometry terminates precisely at the coronary interface, eliminating excess extension and reducing flow disturbance.
Docking Architecture
The MIMAC Dock-2 anchor is deployed via leg-artery access and incorporates two spatially separated magnetic capture points that constrain both translation and rotation. Magnetic alignment is supplemented by passive mechanical features and radiographic verification markers.
Surgical Instrumentation
The GyroPoint head functions as the sole active surgical instrument, maintaining an inertial reference frame decoupled from body curvature and physiologic motion. Interface preparation, docking stabilization, and seal conditioning are performed without rigid force application.
Access Pathway
The BioSheath PeriPath provides a temporary, peristaltic access conduit using anisotropic friction micro-geometry. Components are selectively bio-assimilated post-procedure to reduce foreign body burden.
Subcutaneous Access
A stabilized access leg permits future inspection and intervention using micro-needle tools and advanced optical systems, enabling longitudinal monitoring without reoperation.
Discussion
This approach reframes bypass surgery as a biologically cooperative process. The separation of access, intelligence, and fixation reduces trauma while enabling repeatable precision.
Conclusion
GyroScopic inertial continuum surgery with magnetically docked bypass implants offers a credible pathway toward non-invasive coronary revascularization with superior healing dynamics and long-term accessibility.
Patent-Ready Claim Scaffold
Independent System Claim
-
A coronary bypass system comprising:
a. A Y-junction vascular implant configured to terminate at a coronary artery;
b. A stent-deployable docking anchor including two magnetic alignment elements;
c. An inertial-stabilized surgical head capable of maintaining a fixed pose independent of access path curvature;
d. A peristaltic, sacrificial access conduit formed from bio-assimilating material.
Key Dependent Claim Domains
-
Magnetic alignment geometry constraining rotation and translation
-
Compliance-matched implant body with hemocompatible luminal coatings
-
Gyroscopic inertial stabilization compensating for cardiac motion
-
Anisotropic friction locomotion structures
-
Bio-resorbable access conduit components
-
Subcutaneous access port enabling post-implant interrogation
-
Imaging and force-signature docking verification
Method Claim Themes
-
Dock-and-snap bypass placement without suturing
-
Interface conditioning prior to sealing
-
Biological encapsulation of exterior implant surfaces
-
Long-term vascular interrogation via subcutaneous access